Drug and Therapeutics Bulletin 1998;36:47-48; doi:10.1136/dtb.1998.36647
Copyright © 1998 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Why treatments fail

In March this year, Drug and Therapeutics Bulletin held its sixth annual symposium on ‘Why Treatments Fail’. The subject was chosen in the belief that the more we understand treatment failure, the greater the chances of developing strategies that succeed. The symposium explored failure of medicines at a molecular level; failure of prescribers to put knowledge into practice; failure of prescribers to cope with changes in diagnostic criteria; problems around doctors' and patients' failure to communicate with each other; failures of the NHS to meet patients' expectations; computer programmes that help patients see the potential consequences of treatment failures; the cost of failure to the NHS. Here we summarise the talks, incorporating ideas that arose in discussion.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1998 BMJ Publishing Group Ltd.